Page 24 - Delaware Medical Journal - March/April 2019
P. 24
Evaluation of Delaware Cancer Registry Data According to American College of Surgeons Quality Measures Betsy Cromartie, MA, CTR; Zeinab Baba, DrPH, MS
DISCLAIMER
This analysis was supported by the cooperative agreement number DP17-1701 from the U.S. Centers for Disease Control and Prevention (CDC). Its contents are solely the responsibility of the authors and do not CDC.
Correspondence concerning this article should be addressed to Heather Brown, Chronic Disease Bureau, Division of Public Health, Thomas Collins Building, Suite 11, 540 S. DuPont Highway, Dover, DE 19901; heather.brown@state.de.us; 302-744-1020.
INTRODUCTION
The Delaware Cancer Registry (DCR) is a state central population-based cancer registry, providing data for cancer surveillance and control initiatives at the Division of Public Health as well as for statewide, national, and international partners. DCR data meet the standards for data quality, timeliness, and completeness required by the Centers for Disease Control and Prevention National Program of Cancer Registries (CDC-NPCR) and the North American Association of Central Cancer Registries (NAACCR). An assessment of the quality of cancer care
was undertaken to evaluate the state’s 2015 of-care measures used in the American College of Surgeons Commission on Cancer highlight Delaware’s strengths and areas for CoC’s recommendations.
BACKGROUND
One objective of the Delaware Cancer Registry Advisory Committee (DCRAC) is to improve the quality of Delaware’s cancer data, enabling the use of patient outcomes to evaluate treatment practices. Toward this objective, the DCRAC has promoted usage of the Rapid Quality Reporting System (RQRS) in Delaware hospitals over the
past several years. The DCRAC has also used the CoC’s CP3R as a tool to promote evaluation and improvement of the quality of cancer care. CP3R displays a hospital’s record of care, which is used to promote continuous improvement of patient care and enables hospitals to compare adherence to quality-of-care standards with those of
other facilities. The CP3R currently reports 23 quality measures covering nine primary cancer sites.1 In a previous study, the DCRAC assessed the feasibility of reporting on statewide adherence to CP3R colon cancer quality-of-care measures for Delaware cancer data as a whole. In this study, the CoC’s CP3R 12 Regional Lymph Nodes (12RLN) and Adjuvant Chemotherapy (ACT) measures were evaluated for the Delaware Cancer Registry’s colon cancer cases.2 The DCRAC concluded that it is feasible to examine CP3R measures using data from
the Delaware Cancer Registry. Since then, the DCRAC has published a study on care quality using the Breast Conserving Surgery with Radiation Therapy (BCSRT) CoC quality measure.3
72
Del Med J | March/April 2019 | Vol. 91 | No. 2
